MEI Pharma to Hold Litecoin as Treasury Reserve

MEI Pharma has announced a $100 million private placement to establish Litecoin (LTC) as its primary treasury reserve asset, making it the first publicly traded company on a national exchange to do so. The initiative is supported by Titan Partners Group and GSR, with Litecoin creator Charlie Lee joining MEI’s Board of Directors and GSR serving as treasury management advisor. The Litecoin Foundation and various crypto venture capital firms also participated in the investment. MEI Pharma’s stock jumped over 50% after the announcement, reflecting significant investor enthusiasm. The transaction involves the sale of approximately 29.2 million shares at $3.42 each and is expected to close around July 22, 2025. This move highlights growing institutional interest in Litecoin and marks a milestone in cryptocurrency adoption by public companies.